Latest Insights - page 40 | BiopharmaTrend

Evo 2: Largest Foundation Model for Genomic Research Across All Domains of Life

Evo 2, the largest AI foundation model for biology to date, is now publicly available via NVIDIA BioNeMo (Arc Institute's preprint), offering researchers a tool for analyzing and generating genomic …

Continue ›››

Spore.Bio Secures €23M for Its AI-Driven Photonic Handheld Pathogen Scanner

Spore.Bio, a Paris-based deeptech startup, has raised $23 million in a Series A funding round, led by Singular, just two years after its founding. The company is developing AI-powered microbiology testing …

Continue ›››

Amid Federal Cuts, Recursion's Altitude Lab Launches Pre-Seed Fund

The recent turmoil surrounding federal research funding—including the NIH policy to cap indirect costs at 15%—has left many early-stage biotech startups in financial limbo. In response, Altitude Lab, a biotech …

Continue ›››

Insilico Medicine Reports Benchmarks for its AI-Designed Therapeutics

Insilico Medicine has released benchmarks detailing the timelines and development metrics for 22 preclinical candidate (PCC) nominations achieved between 2021 and 2024. These self-reported metrics offer a view of the …

Continue ›››

AI for Protein Design: DeepMind Alum’s Startup Comes Out of Stealth with $50M

Latent Labs, a company developing AI models for computational protein design, has raised $50 million in funding and announced its emergence from stealth. The funding includes a $40 million Series …

Continue ›››

Receptor.AI and Moexa Harness AI for SMAD3-Targeted Oncology and Fibrosis

Receptor.AI and Moexa Pharmaceuticals Limited have announced a partnership to accelerate the development of Moexa’s SMAD3 inhibitors for cancer and fibrosis. The collaboration aims to integrate AI-driven drug discovery workflows …

Continue ›››

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 oncology approvals, including 11 for …

Continue ›››

Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical Manufacturing Optimization

Basetwo, an AI platform for manufacturing engineers, has raised $11.5 million in Series A funding. The funding will support the development of Basetwo’s Physics AI platform, designed to optimize pharmaceutical …

Continue ›››

Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor

Insilico Medicine, a clinical-stage biotechnology company leveraging generative AI for drug discovery, has dosed the first patient in its global Phase I trial of ISM6331, a novel pan-TEAD inhibitor for …

Continue ›››

Advarra Launches Study Collaboration Solution to Accelerate Clinical Trial Startup

Advarra, a provider of regulatory review solutions and clinical research technology, has introduced its Study Collaboration solution, designed to streamline site activation workflows, improve stakeholder engagement, and enhance visibility across …

Continue ›››

RyboDyn Uncovers Dark Proteome, Secures $4M Pre-Seed for Cancer Immunotherapy

RyboDyn, a biotechnology company targeting the “dark proteome,” has announced the discovery of a previously hidden human proteome and closed a $4 million pre-seed financing round. The funding will advance …

Continue ›››

Icelandic Biotech Raises €26.5M for Clinical-Stage Dementia and Skin Disease Treatments

Arctic Therapeutics (ATx), an Icelandic drug discovery and development company, has closed an oversubscribed €26.5 million Series A financing round. The funding will support the advancement of ATx’s pipeline targeting …

Continue ›››